Laurent C.
- Country
- France
- Department
- Hépatologie
Research Overview
- N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa in Adults with Biopsy‑Confirmed F2–F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa Safety and Tolerability in Adults with F2‑F3 Metabolic Dysfunction‑Associated Steatohepatitis
Data & Insights
Has run more than one trial at 170 of 279 partner sites.
Specializations
Liver Disease Expertise
This investigator specializes in treating advanced non-alcoholic steatohepatitis (NASH) and its progression to liver fibrosis. Their research encompasses both non-cirrhotic and cirrhotic stages of the disease.
- NASH Resolution Strategies
- Fibrosis Management
- Cirrhosis Treatment
Their work includes evaluation of liver histology improvements and fibrosis regression in patients.
Metabolic Health Focus
The investigator studies metabolic dysfunction-associated steatohepatitis (MASH) and its relationship with liver health. Their expertise extends to analyzing liver fat content and metabolic markers.
- Metabolic Liver Disease
- Hepatic Fat Reduction
- Metabolic Biomarkers
They evaluate therapeutic approaches for metabolic liver conditions and their clinical outcomes.
Clinical Outcomes Research
Their research focuses on liver-related clinical outcomes and mortality assessment in patients with chronic liver diseases. They monitor hepatic decompensation events and disease progression markers.
- Mortality Assessment
- Disease Progression Monitoring
- Long-term Patient Outcomes
The investigator tracks comprehensive clinical endpoints including liver transplantation needs and complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.